July 9, 2020
…through hospital units, seeing patients and learning on the job from physicians. Kim Parra-Guerrero (left), UC San Diego medical student, and her mother, who moved to the U.S. from Colombia “Suddenly, you’re not sitting at your desk, studying for 12 hours a day, and that can be a rough transition…
June 13, 2023
Loomba will lead the division at UC San Diego School of Medicine, building upon a team that shines a light on UC San Diego Health’s tripartite mission.
July 20, 2023
The ceremony recognized the work of individuals and teams whose improvement projects made a positive impact for providers, staff and patients at UC San Diego Health.
September 11, 2019
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
November 20, 2018
Researchers at University of California San Diego School of Medicine with colleagues at the National Institutes of Health and UC San Francisco report finding infectious agent in the eyes of deceased sCJD patients, making the eye a potential source for early CJD detection and prevention of disease.
August 8, 2019
The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.
February 7, 2023
A novel drug combination for leukemia, pioneered at UC San Diego Health, provides patients with a better treatment option that results in less side effects and can put patients in remission.
March 18, 2020
New study finds gene therapy improved cardiac, muscle and liver function in Danon disease mouse models.
April 28, 2021
UC San Diego School of Medicine researchers discovered one way in which SARS-CoV-2 hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.
December 13, 2022
UC San Diego scientists identify a new molecular model and potential therapeutic target for gout, the most common form of inflammatory arthritis.
